Lab studies point to platelet action as key to anti-tumor effect Studies abound that point to a role for plain old aspirin in keeping deadly cancers at bay. While aspirin is not yet part of mainstream treatment for any cancer, it is recommended by the U.S. Preventive Services Task Force for certain adults to help...
Author: admin
How to stop pain from serious burns using epigenetics
Spinal cord. The unpleasant sensation sparked by the nervous system when confronted with a harmful stimulus can be alleviated by blocking a genetic marker that switches off the activity of the neurons involved. Jose Vicente Torres Pérez, a Spanish researcher who works at Imperial College in London, has trialled this innovative pain relief therapy on...
World-first trial shows improving diet can treat major depression
A new trial from Deakin University has shown for the first time that improving diet quality can treat major depression. Director of Deakin’s Food and Mood Centre Professor Felice Jacka said the results of her team’s new study offered a possible new treatment approach to depression, one of the world’s most prevalent and costly medical...
Revolutionary approach for treating glioblastoma works with human cells
Revolutionary approach for treating glioblastoma works with human cells (Chapel Hill, N.C. – Feb. 1, 2017) — In a rapid-fire series of breakthroughs in just under a year, researchers at the University of North Carolina at Chapel Hill have made another stunning advance in the development of an effective treatment for glioblastoma, a common and...
Middle-aged adults who take more than 5 pills a day are 3 times more likely to become frail – increasing their risk of falls, disability and even death
Mixing medications causes pensioners to weaken sooner, new research found The practice of taking more than 5 medicines a day is known as polypharmacy People who took more than 10 drugs daily were twice as likely to become frail Taking more than five prescription tablets a day causes pensioners to become frail, new research suggests....
Novel combination of drugs 'could eliminate HIV', scientists claim as they start groundbreaking human trial
Case Western Reserve University scientists are combining two AIDS treatments The two properties have already been shown to reduce the viral load of HIV But researchers believe they could go as far as to reduce ‘latent HIV reservoirs’ – HIV-infected cells which do not actively produce HIV so are harder to target HIV could be...
Scientists 'supercharge' antibiotics to tear superbugs apart: Study hailed as groundbreaking amid race to combat drug resistance
Scientists have found a way to ‘supercharge’ antibiotics to ‘blow up’ superbugs The drugs bind to bacteria to kill them – like putting a key in the lock of a door But when one drug exerts such physical force, it can ‘rip the door off its hinges’ Researchers hope this is a way to combat...
New dementia pill made entirely from CHOCOLATE hits shelves in Britain after cocoa was found to improve blood flow and help the heart
Flavanols extracted from cocoa help tackle cholesterol levels and blood flow But effective dose would be 400g of dark chocolate, containing 2,429 calories New pill contains the condensed anti-oxidant nutrient in its purest form A groundbreaking new pill that can help cut the risk of heart attacks, strokes and dementia is now available in the...
Baker's yeast enzyme could help treat leukemia, study suggests
Acute lymphoblastic leukemia is the most common form of childhood leukemia, accounting for around 3 in 4 cases in the United States. In a new study, researchers reveal how a compound isolated from baker’s yeast can help to treat the disease. Researchers suggest that an enzyme found in baker’s yeast has the potential to kill...
'In vivo' reprogramming induces signs of telomere rejuvenation
A representative image of double immunofluorescence against OCT4 (red) and TRF1 (green) proteins in the pancreas of a reprogrammable mouse. During the ‘in vivo’ reprogramming process, cellular telomeres are extended due to an increase in endogenous telomerase. This is the main conclusion of a paper published in Stem Cell Reports by a team from the Spanish...